Literature DB >> 23905570

Predictors of bronchopulmonary dysplasia and pulmonary hypertension in newborn children.

Zarqa Ali1, Peter Schmidt, James Dodd, Dorthe Lisbeth Jeppesen.   

Abstract

INTRODUCTION: Infants with bronchopulmonary dysplasia (BPD) are at high risk of developing cardiovascular sequelae in the form of pulmonary hypertension (PH) which significantly increases morbidity and mortality. The aim of this study was to evaluate the incidence of BPD, to identify characteristics associated with BPD and to identify characteristics associated with PH in infants with BPD.
MATERIAL AND METHODS: A retrospective study was performed. Data were obtained from a regional neonatal database and by reviewing medical records of infants admitted during the 2002-2010 period. A total of 400 infants with a birth weight (BW) < 1,500 g were identified. Eight were excluded and 74 infants met the criteria for BPD. A total of 17 infants with BPD had PH.
RESULTS: We found that the incidence of BPD at the Neonatal Department at Hvidovre Hospital between January 2002 and December 2010 was 18%. Infants with BPD differed significantly from infants without BPD with regard to the following characteristics: Infants with BPD more frequently had a lower gestational age and BW, intubation at birth, mechanical ventilation within 24 hours of birth, a lower Apgar score at one minute and five minutes. The incidence of PH was 23% among infants with BPD. Furthermore, we found a significantly larger frequency of intubation at birth, postnatal infection, longer duration of continuous positive airway pressure treatment and use of oxygen therapy among infants with PH and BPD than among the remaining infants.
CONCLUSION: The incidence of BPD was 18%. Low gestational age was found to be the most important factor associated with development of BPD. Among BPD infants, postnatal infection was significantly associated with PH. Further prospective studies including routine echocardiography are needed to evaluate risk factors for PH. FUNDING: not relevant. TRIAL REGISTRATION: not relevant.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23905570

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  17 in total

Review 1.  Bronchopulmonary dysplasia and pulmonary hypertension: a meta-analysis.

Authors:  G Al-Ghanem; P Shah; S Thomas; L Banfield; S El Helou; C Fusch; A Mukerji
Journal:  J Perinatol       Date:  2017-01-12       Impact factor: 2.521

Review 2.  Pulmonary hypertension: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases.

Authors:  Eric D Austin; Steven M Kawut; Mark T Gladwin; Steven H Abman
Journal:  Ann Am Thorac Soc       Date:  2014-04

3.  Plasma asymmetric dimethylarginine levels are increased in neonates with bronchopulmonary dysplasia-associated pulmonary hypertension.

Authors:  Jennifer K Trittmann; Eric Peterson; Lynette K Rogers; Bernadette Chen; Carl H Backes; Mark A Klebanoff; Leif D Nelin
Journal:  J Pediatr       Date:  2014-10-11       Impact factor: 4.406

4.  Analysis of short-term treatment with the phosphodiesterase type 5 inhibitor tadalafil on long bone development in young rats.

Authors:  Luqiang Wang; Haoruo Jia; Robert J Tower; Michael A Levine; Ling Qin
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-06-19       Impact factor: 4.310

Review 5.  Progress in the diagnosis and management of pulmonary hypertension in children.

Authors:  Jeremy Nicolarsen; Dunbar Ivy
Journal:  Curr Opin Pediatr       Date:  2014-10       Impact factor: 2.856

6.  Point Prevalence, Clinical Characteristics, and Treatment Variation for Infants with Severe Bronchopulmonary Dysplasia.

Authors:  Milenka Cuevas Guaman; Jason Gien; Christopher D Baker; Huayan Zhang; Eric D Austin; Joseph M Collaco
Journal:  Am J Perinatol       Date:  2015-03-04       Impact factor: 1.862

Review 7.  Pulmonary Hypertension in Preterm Infants with Bronchopulmonary Dysplasia.

Authors:  Christopher D Baker; Steven H Abman; Peter M Mourani
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2014-03-01       Impact factor: 1.349

8.  The mechanosensitive ion channel TRPV4 is a regulator of lung development and pulmonary vasculature stabilization.

Authors:  Joshua T Morgan; Wade G Stewart; Robert A McKee; Jason P Gleghorn
Journal:  Cell Mol Bioeng       Date:  2018-07-16       Impact factor: 2.321

9.  Incidence, risk factors, and outcomes of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.

Authors:  Katelyn MacKenzie; Kathy Cunningham; Sumesh Thomas; Tapas Mondal; Salhab El Helou; Prakesh S Shah; Amit Mukerji
Journal:  Paediatr Child Health       Date:  2019-03-10       Impact factor: 2.253

10.  Differences in Comorbidities and Clinical Burden of Severe Bronchopulmonary Dysplasia Based on Disease Severity.

Authors:  Hye-Rim Kim; Young Hwa Jung; Beyong Il Kim; So Young Kim; Chang Won Choi
Journal:  Front Pediatr       Date:  2021-07-02       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.